Investor profile
Matthew Foy
Venture capital & CEO and Managing Partner at Avante Biocapital, Senior Advisor at SR One Capital Management
Matthew Foy is a Senior Advisor at SR One Capital Management, whose known portfolio counts 10 companies.
Is Matthew Foy a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell TherapyClinical-stage BiotechDrug DiscoveryGeneticsGenomicsLife SciencePharmaTherapeuticsTransatlantic
Contacts
Affiliated funds' portfolios
CEO and Managing Partner at Avante Biocapital, whose known portfolio counts 1 company
- Avante AI
Senior Advisor at SR One Capital Management, whose known portfolio counts 10 companies
- VeraDermics
- Avenzo Therapeutics
- Crystalys Therapeutics
- Addition Therapeutics
- CORXEL Pharmaceuticals
- MISSION Therapeutics
- CHARM Therapeutics
- AirNexis Therapeutics
- Immutrin
- Poplar Therapeutics
Investor Profile
Matthew Foy is listed against sector Healthcare, and focus areas Biotech, Cell Therapy, Clinical-stage Biotech and Drug Discovery in the database.
Stage-wise, the deals at SR One Capital Management cluster around Growth, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Matthew Foy is worth approaching.
Colleagues
Christopher Chai
Venture Partner
San Francisco, United States
Amit Shah
Principal
London, United Kingdom
Jake Nunn
Partner
San Francisco, United States
Jill Carroll
Partner
San Mateo, United States
Rajeev Dadoo
Managing Partner
San Francisco, United States
Philip Habib
Managing Director
London, United Kingdom
Michael Diem
Partner
Conshohocken, United States
Frequently asked questions
Who is Matthew Foy?
Matthew Foy is a venture capital investor based in London, England, United Kingdom, listed as Senior Advisor at SR One Capital Management. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Matthew Foy personally.
What does Matthew Foy invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Clinical-stage Biotech and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Matthew Foy invest at?
SR One Capital Management appears in Growth, Seed and Series A rounds across its known deals, and Matthew Foy is listed there as Senior Advisor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Matthew Foy listed at?
Matthew Foy is listed as Senior Advisor at SR One Capital Management. 7 other people in the database share a firm with Matthew Foy.
How do I contact Matthew Foy?
An email address, a phone number and a LinkedIn page are on file for Matthew Foy. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal